29 October 2009

WADA 2010 Prohibited List

WADA 2010 Prohibited List Now Published@WADA

The 2010 List reflects the latest scientific advances and offers a number of noteworthy changes compared to the 2009 List:

The status of salbutamol, a beta-2 agonist, will change. Therapeutic use of inhaled salbutamol will not be prohibited as of January 1, 2010. If the urinary concentration is above 1,000 nanograms per millilitre, there will be a presumption that the substance was not taken by inhalation and the athlete will have the burden to demonstrate through a controlled pharmacokinetic study that the level found in his urine was the result of therapeutic inhaled use.

T/E Ratio Follow-Up
No further collections or analyses will be required in cases where the testosterone to epitestosterone (T/E) ratio is greater than 4 and an isotope ratio mass spectrometry (IRMS) test or any other reliable analytical method has not revealed evidence of exogenous administration of a prohibited substance.

Pseudoephedrine will be reintroduced to the List and will be prohibited above 150 micrograms per millilitre.

No comments: